Omar A. Alkharabsheh, MD

Dileo, Rachel; Mewawalla, Prerna; Babu, Kalaivani; Yin, Yue; Strouse, Christopher; Chen, Ethan; Shaikh, Hira; Davis, James A; Green, Kimberly M; Alkharabsheh, Omar; Rashid, Aliya; Pokhrel, Bidushi; Ahmed, Nausheen; Abdallah, Al-Ola; Hashmi, Hamza 2025. A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma. Blood cancer journal, 15 1, 34

Mewawalla, Prerna; Dileo, Rachel; Yin, Yue; Strouse, Christopher; Shaikh, Hira; Davis, James A; Alkharabsheh, Omar; Rashid, Aliya; Ahmed, Nausheen; Abdallah, Al-Ola; Hashmi, Hamza 2025. Real-World Outcomes of Sequential BCMA-directed therapies in Relapsed Refractory Multiple Myeloma After Belantamab Exposure. Clinical lymphoma, myeloma & leukemia, ,

Zayad, Anas; Ahmed, Nausheen; Mahmoudjafari, Zahra; Skikne, Barry S; Lin, Tara; Mushtaq, Muhammad U; McGuirk, Joseph; Lutfi, Forat; Bhurtel, Evguenia; Bhutani, Manisha; Anwar, Faiz; Alkharabsheh, Omar; Shebli, Atrash; Abdallah, Al-Ola 2025. The Impact of Sponsors on Development of Clinical Research in Multiple Myeloma and AL Amyloidosis: An In-Depth Analysis. Clinical lymphoma, myeloma & leukemia, 25 8, e600-e603

Atallah, Rawan; Ahmed, Nausheen; Ayoobkhan, Fathima; Saif, Md Saiful Islam; Logan, Emerson; Shrestha, Anuj; Anwer, Faiz; Mahmoudjafari, Zahra; Mushtaq, Muhammed Umair; Hashmi, Hamza; Ganguly, Siddhartha; McGuirk, Joseph; Shebli, Atrash; Abdallah, Al-Ola; Banerjee, Rahul; Alkharabsheh, Omar 2024. TACTUM: Trends in Access to Cellular Therapies in Multiple Myeloma, Perspectives of Treating Versus Referring Physicians. Transplantation and cellular therapy, 30 9, 925.e1-925.e6

Abdallah, Al-Ola; Mahmoudjafari, Zahra; Ahmed, Nausheen; Cui, Wei; Shune, Leyla; McGuirk, Joseph; Mohan, Meera; Mohyuddin, Ghulam Rehman; Afrough, Aimaz; Alkharabsheh, Omar; Atrash, Shebli 2023. Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myeloma. European journal of haematology, 110 6, 626-632

Afrough, Aimaz; Atrash, Shebli; Paul, Barry; Ouchveridze, Evguenia; Ahmed, Nausheen; Mahmoudjafari, Zahra; Bashir, Anam; Alkharabsheh, Omar; Hashmi, Hamza; Abdallah, Al-Ola 2023. Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab-Naïve Relapsed Multiple Myeloma. Cancers, 15 19,

Alkharabsheh, Omar; Bellman, Polina; Mahmoudjafari, Zahra; Cui, Wei; Atrash, Shebli; Paul, Barry; Hashmi, Hamza; Shune, Leyla; Ahmed, Nausheen; Abdallah, Al-Ola 2023. Adverse Hematological and Non-Hematological Events in Patients With Relapsed/Refractory Multiple Myeloma That Are Responsive to Daratumumab, Pomalidomide and Dexamethasone. Journal of hematology, 12 1, 1-6

Atrash, Shebli; Mammadzadeh, Aytaj; Peng, Fulei; Alkharabsheh, Omar; Afrough, Aimaz; Cui, Wei; Mahmoudjafari, Zahra; Abdallah, Al-Ola; Hashmi, Hamza 2023. Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy. Cancers, 15 11,

Manne, Ashish; Mulekar, Madhuri; Escobar, Daisy; Prodduturvar, Pranitha; Fahmawi, Yazan; Henderson, Phillip; Abdul-Rahim, Osama; Hussain, Zeiad; Liles, Spencer; Fonseca, Annabelle; Howard, John Harrison; Mneimneh, Wadad; Gilbert, Robert; Alkharabsheh, Omar; Pai, Sachin; White, Zachary B; Nelson, Cindy; Khushman, Moh'd 2023. The adherence to the American Association for the Study of Liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survival. Journal of cancer research and therapeutics, 19 5, 1103-1108

Njomen, Evert; Vanecek, Allison; Lansdell, Theresa A; Yang, Ya-Ting; Schall, Peter Z; Harris, Christi M; Bernard, Matthew P; Isaac, Daniel; Alkharabsheh, Omar; Al-Janadi, Anas; Giletto, Matthew B; Ellsworth, Edmund; Taylor, Catherine; Tang, Terence; Lau, Sarah; Bailie, Marc; Bernard, Jamie J; Yuzbasiyan-Gurkan, Vilma; Tepe, Jetze J 2022. Small Molecule 20S Proteasome Enhancer Regulates MYC Protein Stability and Exhibits Antitumor Activity in Multiple Myeloma. Biomedicines, 10 5,

Alkharabsheh, Omar; Alsayed, Alhareth; Morlote, Diana M; Mehta, Amitkumar 2021. Cerebral Invasive Aspergillosis in a Case of Chronic Lymphocytic Leukemia with Bruton Tyrosine Kinase Inhibitor. Current oncology (Toronto, Ont.), 28 1, 837-841

Alkharabsheh, Omar; Trisel, Zachary; Badami, Sunil; Aljama, Mohammed A; Sidiqi, M Hasib 2021. Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled Promises. Cancers, 14 1,

Khushman, Moh'd; Prodduturvar, Pranitha; Mneimneh, Wadad; Zotto, Valeria Dal; Akbar, Shalla; Grimm, Leander; Rider, Paul; Hunter, John; Alkharabsheh, Omar; Patel, Girijesh Kumar; Fabregas, Jesus C; Singh, Ajay P 2021. The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma. Oncotarget, 12 15, 1490-1498

Manne, Ashish; Mulekar, Madhuri S; Escobar, Daisy E; Alsayed, Alhareth; Sharma, Gaurav; Prodduturvar, Pranitha; Khushman, Moh'd; Howard, John Harrison; Gilbert, Robert; Alkharabsheh, Omar 2021. Clinical and Hematological Predictors of High-Grade Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors. Journal of clinical medicine research, 13 5, 268-275

Alkharabsheh, Omar; Patnaik, Mrinal M; Gangat, Naseema; Begna, Kebede H; Alkhateeb, Hassan B; Shah, Mithun Vinod; Hogan, William J; He, Rong; Greipp, Patricia; Nguyen, Phuong L; Litzow, Mark R; Al-Kali, Aref 2020. Impact of marrow blasts percentage on high-grade myelodysplastic syndrome assessed using revised international prognostic scoring system. Annals of hematology, 99 3, 513-518

Alkharabsheh, Omar; Sidiqi, M Hasib; Aljama, Mohammed A; Gertz, Morie A; Frankel, Arthur E 2020. The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors. Acta haematologica, 143 2, 118-123

Fahmawi, Yazan; Smith, Clayton; Grimm, Leander; Khullar, Shikha; Rider, Paul; Hunter, John; Iliff, Greire; Mneimneh, Wadad; Roveda, Kelly; Wang, Bin; Prodduturvar, Pranitha; Alkharabsheh, Omar; McCormick, Ben; Mizrahi, Meir; Khushman, Moh'd 2020. Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer. Clinical colorectal cancer, 19 4, e281-e287

Alkharabsheh, Omar A; Saadeh, Salwa S; Zblewski, Darci L; Gangat, Naseema; Begna, Kebede H; Elliott, Michelle A; Alkhateeb, Hassan B; Patnaik, Mrinal S; Hogan, William J; Litzow, Mark R; Al-Kali, Aref 2019. Frequency of venous thrombotic events in patients with myelodysplastic syndrome and 5q deletion syndrome during lenalidomide therapy. Annals of hematology, 98 2, 331-337

Alkharabsheh, Omar; Frankel, Arthur E 2019. Clinical Activity and Tolerability of SL-401 (Tagraxofusp): Recombinant Diphtheria Toxin and Interleukin-3 in Hematologic Malignancies. Biomedicines, 7 1,

Fahmawi, Yazan; Campos, Yesica; Khushman, Moh'd; Alkharabsheh, Omar; Manne, Ashish; Zubair, Haseeb; Haleema, Saadia; Polski, Jacek; Bessette, Sabrina 2019. Vitamin B12 deficiency presenting as pseudo-thrombotic microangiopathy: a case report and literature review. Clinical pharmacology : advances and applications, 11 , 127-131

Alkharabsheh, Omar; Al-Kali, Aref; Saadeh, Salwa; He, Rong; Viswanatha, David; Greipp, Patricia; Reichard, Kaaren; Shah, Mithun; Gangat, Naseema; Patnaik, Mrinal; Hogan, William; Litzow, Mark; Alkhateeb, Hassan; Nguyen, Phuong L 2018. The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS. American journal of hematology, 93 11, E355-E357

Alkharabsheh, Omar; Kannarkatt, Paul; Kannarkatt, Joseph; Karapetyan, Lilit; Laird-Fick, Heather S; Al-Janadi, Anas 2018. An overview of the toxicities of checkpoint inhibitors in older patients with cancer. Journal of geriatric oncology, 9 5, 451-458

Alkharabsheh, Omar; Saadeh, Salwa S; Patnaik, Mrinal S; Alkhateeb, Hassan; Gangat, Naseema; Begna, Kebede H; Hogan, William J; Greipp, Patricia T; He, Rong; Nguyen, Phuong L; Litzow, Mark R; Al-Kali, Aref 2018. Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes. American journal of hematology, 93 12, E398-E401

Kannarkatt, Joseph; Alkharabsheh, Omar; Tokala, Hemasri; Dimitrov, Nikolay V 2016. Metformin and Angiogenesis in Cancer - Revisited. Oncology, 91 4, 179-184